For this purpose, we performed IHC using antibodies against smooth muscle actin (SMA), transforming factor (TGF)-beta and tenascin C, which serve as markers for cancer-associated fibroblasts, cytokines and the extracellular matrix, respectively. Here, SMN1 is linked to cancer.